Improving Sleep and Cognition in Alzheimer's Disease

Alzheimer's Disease (AD) is a brain disorder affecting memory and thinking. This study aims to improve sleep and thinking skills using a dietary supplement called citicoline. Sleep problems affect many people with AD, impacting their lives and those who care for them. Citicoline has been tested before and is considered safe for AD patients. The study will compare citicoline with a placebo (a harmless pill with no active ingredient) to see if it helps with sleep and thinking.

The study will include 20 people with AD over three months. Participants will take citicoline or a placebo for this period. They will visit the study team twice, once at the beginning and once three months later. Sleep quality and thinking skills will be measured using special tests.

• The study lasts for 3 months with two visits.
• Participants will take a daily dose of citicoline or a placebo.
• AD diagnosis, being 18 or older, and access to the internet are needed to join.